14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.97 $10.47 Wednesday, 1st May 2024 ZYME stock ended at $8.76. This is 2.10% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.26% from a day low at $8.55 to a day high of $9.00.
90 days $7.97 $13.14
52 weeks $6.02 $13.14

Historical Zymeworks Inc prices

Date Open High Low Close Volume
Oct 31, 2023 $6.92 $7.18 $6.79 $7.02 408 700
Oct 30, 2023 $6.69 $7.07 $6.69 $6.99 326 874
Oct 27, 2023 $6.75 $6.75 $6.54 $6.65 480 359
Oct 26, 2023 $7.00 $7.02 $6.59 $6.68 321 092
Oct 25, 2023 $6.91 $7.01 $6.79 $6.97 364 106
Oct 24, 2023 $7.02 $7.09 $6.96 $7.01 310 618
Oct 23, 2023 $7.12 $7.20 $6.97 $7.00 373 054
Oct 20, 2023 $7.24 $7.24 $7.11 $7.19 264 828
Oct 19, 2023 $7.14 $7.32 $7.07 $7.21 335 372
Oct 18, 2023 $7.23 $7.32 $7.09 $7.16 249 659
Oct 17, 2023 $7.02 $7.27 $7.02 $7.25 329 616
Oct 16, 2023 $6.52 $7.07 $6.46 $7.05 462 830
Oct 13, 2023 $6.41 $6.52 $6.26 $6.50 393 998
Oct 12, 2023 $6.50 $6.50 $6.22 $6.42 444 720
Oct 11, 2023 $6.44 $6.50 $6.35 $6.50 303 685
Oct 10, 2023 $6.30 $6.46 $6.22 $6.45 255 079
Oct 09, 2023 $6.38 $6.38 $6.12 $6.28 226 213
Oct 06, 2023 $6.25 $6.51 $6.21 $6.40 323 179
Oct 05, 2023 $6.21 $6.28 $6.07 $6.26 320 163
Oct 04, 2023 $6.18 $6.24 $6.02 $6.22 449 752
Oct 03, 2023 $6.20 $6.24 $6.09 $6.18 415 164
Oct 02, 2023 $6.32 $6.39 $6.15 $6.19 587 924
Sep 29, 2023 $6.29 $6.43 $6.28 $6.34 346 588
Sep 28, 2023 $6.22 $6.31 $6.12 $6.25 423 550
Sep 27, 2023 $6.40 $6.46 $6.17 $6.22 399 141
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT